Brea-based Envista Holdings Corp. (NYSE: NVST), a maker of dental products, today announced the appointment of Paul Keel as its new chief executive officer and a member of the board, effective May 1.
Envista counts a market value of $3.3 billion.
Keel was previously CEO of global technology company Smiths Group PLC. Smith’s medical division was acquired by ICU Medical Inc. for $2.4 billion in 2022.
“Paul’s strong track record as CEO of a public, diversified, global innovation company makes him the right leader for Envista at this stage in our growth journey,” Chairman Scott Huennekens said in a statement.
Keel succeeds Amir Aghdaei, who will remain with the company as a senior advisor.
For more information, see the April 22 print edition of the Orange County Business Journal.
